Cover Image
市場調查報告書

十二指腸癌症:全球臨床實驗檢討

Duodenal Cancer Global Clinical Trials Review, H2, 2017

出版商 GlobalData 商品編碼 297516
出版日期 內容資訊 英文 57 Pages
訂單完成後即時交付
價格
Back to Top
十二指腸癌症:全球臨床實驗檢討 Duodenal Cancer Global Clinical Trials Review, H2, 2017
出版日期: 2017年07月28日 內容資訊: 英文 57 Pages
簡介

本報告提供全球十二指腸癌症治療藥臨床實驗的相關調查,彙整各地區,Phase別,各狀態臨床實驗趨勢,主要企業和研究所等臨床實驗簡介,為您概述為以下內容。

目錄

簡介

  • 十二指腸癌症
  • 報告指南

臨床試驗:各地區

  • 臨床試驗:各國
    • 對臨床實驗有所貢獻的前幾名國家 - 亞太地區
    • 對臨床實驗有所貢獻的前五國 - 歐洲
    • 對臨床實驗有所貢獻的前幾名國家 - 北美

臨床試驗 G7各國

臨床試驗 G7各國,Phase別

臨床試驗 G7各國,各臨床實驗狀態

臨床試驗 E7各國

臨床試驗 Phase別

  • 進行中的臨床實驗:Phase別

臨床試驗:各臨床實驗狀態

未完成的臨床實驗

每段時期的實驗人數

有力的贊助商

  • 主要參與臨床實驗的企業

潛力治療藥物

  • 臨床試驗簡介
  • 臨床試驗概要:前幾名企業
    • Silence Therapeutics AG
    • Oncothyreon Inc.
    • F. Hoffmann-La Roche Ltd.
  • 臨床試驗概要:最高級大學 / 研究機關 / 醫院
    • National Cancer Institute
    • 和歌山縣立醫科大學
    • 名古屋大學
    • Seoul National University Hospital
    • 東京大學
    • Thomas Jefferson University
    • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
    • Odense University Hospital
    • Weill Cornell Medical College
    • USC Norris Comprehensive Cancer Center

5件主要臨床簡介

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 二次調查
  • 關於GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4404CTIDB

GlobalData's clinical trial report, "Duodenal Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Duodenal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Duodenal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Clinical Trials by G7 Countries: Proportion of Duodenal Cancer to Oncology Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by Phase 17
  • In Progress Trials by Phase 18
  • Clinical Trials by Trial Status 19
  • Clinical Trials by End Point Status 21
  • Subjects Recruited Over a Period of Time 22
  • Clinical Trials by Sponsor Type 23
  • Prominent Sponsors 24
  • Top Companies Participating in Duodenal Cancer Therapeutics Clinical Trials 26
  • Prominent Drugs 28
  • Clinical Trial Profile Snapshots 29

Appendix 54

  • Abbreviations 54
  • Definitions 54
  • Research Methodology 55
  • Secondary Research 55
  • About GlobalData 56
  • Contact Us 56
  • Disclaimer 56
  • Source 57

List of Tables

List of Tables

  • Duodenal Cancer Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Duodenal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Duodenal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Duodenal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
  • Duodenal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
  • Duodenal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
  • Proportion of Duodenal Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 14
  • Duodenal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Duodenal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Duodenal Cancer Therapeutics, Global, Clinical Trials by Phase, 2017* 17
  • Duodenal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 18
  • Duodenal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 20
  • Duodenal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 21
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 22
  • Duodenal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 23
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28

List of Figures

List of Figures

  • Duodenal Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Duodenal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Duodenal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Duodenal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
  • Duodenal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
  • Proportion of Duodenal Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 14
  • Duodenal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Duodenal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Duodenal Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2017* 17
  • Duodenal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 18
  • Duodenal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 19
  • Duodenal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 21
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 22
  • Duodenal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 23
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 24
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28
  • GlobalData Methodology 55
Back to Top